The present invention provides novel pyrazoles that are useful as cannabinoid receptor antagonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, and/or cardiometabolic disorders.
本发明提供了一种新型
吡唑,可作为
大麻素受体拮抗剂,并提供了其药物组合物和治疗肥胖、糖尿病和/或心脏代谢紊乱的方法。